Saba Capital sells abrdn Life Sciences (HQL) shares for $215,856
NeutralFinancial Markets

Saba Capital has sold its shares in abrdn Life Sciences for a total of $215,856. This transaction reflects the firm's ongoing investment strategy.
Editor’s Note: This sale is significant as it highlights Saba Capital's investment decisions and market movements within the life sciences sector, which can impact investor sentiment and market dynamics.
— Curated by the World Pulse Now AI Editorial System